UBS Maintains Buy on Ovintiv, Lowers Price Target to $61
Portfolio Pulse from Benzinga Newsdesk
UBS analyst Josh Silverstein maintains a Buy rating on Ovintiv (NYSE:OVV) but lowers the price target from $66 to $61.

August 09, 2024 | 3:09 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
UBS analyst Josh Silverstein maintains a Buy rating on Ovintiv but lowers the price target from $66 to $61.
The Buy rating suggests continued confidence in Ovintiv's performance, but the lowered price target indicates a more cautious outlook. This mixed signal is likely to result in a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100